Tidal Investments LLC Purchases 14,631 Shares of Colgate-Palmolive (NYSE:CL)

Tidal Investments LLC raised its position in Colgate-Palmolive (NYSE:CL) by 31.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 61,646 shares of the company’s stock after buying an additional 14,631 shares during the quarter. Tidal Investments LLC’s holdings in Colgate-Palmolive were worth $5,551,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Legacy Trust lifted its position in Colgate-Palmolive by 1.7% in the 1st quarter. Legacy Trust now owns 6,925 shares of the company’s stock valued at $624,000 after acquiring an additional 116 shares in the last quarter. Checchi Capital Advisers LLC raised its stake in shares of Colgate-Palmolive by 1.5% in the first quarter. Checchi Capital Advisers LLC now owns 7,829 shares of the company’s stock worth $705,000 after purchasing an additional 118 shares during the last quarter. Regal Investment Advisors LLC lifted its holdings in shares of Colgate-Palmolive by 1.6% in the fourth quarter. Regal Investment Advisors LLC now owns 7,574 shares of the company’s stock valued at $604,000 after purchasing an additional 121 shares in the last quarter. M&G Investment Management Ltd. boosted its position in shares of Colgate-Palmolive by 0.3% during the fourth quarter. M&G Investment Management Ltd. now owns 49,269 shares of the company’s stock valued at $3,942,000 after buying an additional 125 shares during the last quarter. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors grew its holdings in Colgate-Palmolive by 3.8% during the first quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors now owns 3,374 shares of the company’s stock worth $304,000 after buying an additional 125 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

CL traded up $0.59 on Thursday, hitting $99.78. The company’s stock had a trading volume of 1,440,811 shares, compared to its average volume of 4,404,379. The company’s 50 day simple moving average is $96.15 and its 200-day simple moving average is $90.54. The company has a quick ratio of 0.28, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $101.42. The firm has a market cap of $81.53 billion, a P/E ratio of 31.39, a price-to-earnings-growth ratio of 3.52 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm had revenue of $5.06 billion during the quarter, compared to analyst estimates of $5 billion. During the same period last year, the company earned $0.77 earnings per share. The business’s revenue for the quarter was up 4.9% on a year-over-year basis. Analysts forecast that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.00%. The ex-dividend date of this dividend is Friday, July 19th. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on CL shares. Evercore ISI raised their price objective on Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Bank of America boosted their price target on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. BNP Paribas started coverage on shares of Colgate-Palmolive in a research note on Monday, June 24th. They issued an “outperform” rating and a $109.00 price objective for the company. Argus lifted their target price on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research report on Wednesday, May 15th. Finally, Wells Fargo & Company upped their target price on Colgate-Palmolive from $92.00 to $97.00 and gave the company an “equal weight” rating in a report on Wednesday, July 10th. Seven analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $101.11.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the transaction, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the transaction, the insider now directly owns 13,924 shares in the company, valued at $1,309,691.44. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares in the company, valued at $297,328.07. The disclosure for this sale can be found here. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.